<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04853212</url>
  </required_header>
  <id_info>
    <org_study_id>APHP210332</org_study_id>
    <secondary_id>2020-A03244-35</secondary_id>
    <nct_id>NCT04853212</nct_id>
  </id_info>
  <brief_title>The Role of Intestinal Microbiota Dysbiosis in the Development of Spondyloarthritis</brief_title>
  <acronym>RUMINOSPA</acronym>
  <official_title>The Role of Dysbiosis of Intestinal Microbiota in the Development of Spondyloarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this case-control study aims to explore the role of bacterium&#xD;
      Ruminococcus gnavus (R. gnavus) with intestinal biopsy and faecal sampling in the initiation&#xD;
      and the development of spondyloarthritis (SPA) in comparison with health control subjets&#xD;
      (patients without chronic disease but have indication to digestive endoscopy).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      As secondary objectives, the study aims:&#xD;
&#xD;
        -  to research the abundance of bacterial strain of R. gnavus in mucosal sampling by&#xD;
           biopsy;&#xD;
&#xD;
        -  to study the interaction between R. gnavus bacterium and mucus from histological&#xD;
           sampling;&#xD;
&#xD;
        -  to correlate the expression of genes of intestinal mucus with the variations of&#xD;
           identified microbiota of mucus biopsy;&#xD;
&#xD;
        -  to study the interaction between bacteria and intestinal epithelial cells during&#xD;
           culture;&#xD;
&#xD;
        -  to demonstrate perturbations of the immune responses by dysbiosis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2021</start_date>
  <completion_date type="Anticipated">June 2023</completion_date>
  <primary_completion_date type="Anticipated">June 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Isolation and characterization of R. gnavus</measure>
    <time_frame>At the end of study, up to 2 years</time_frame>
    <description>Isolation and characterization of R. gnavus bacterium from intestinal biopsy.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bacteria analysis</measure>
    <time_frame>At the end of study, up to 2 years</time_frame>
    <description>Analysis of repartition of R. gnavus bacterium in each group and the comparison between 2 groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bacterial strain's abundance</measure>
    <time_frame>At the end of study, up to 2 years</time_frame>
    <description>Compare the abundance by RT-q-PCR of bacterial strain (R. gnavus) between mucus biopsy sampling and faecal sampling, collected from PCR patients or control subjects respectively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mucin-degradation of Ruminococcus gnavus</measure>
    <time_frame>At the end of study, up to 2 years</time_frame>
    <description>Study the ability of the strain to grow on mucins of intestinal biopsy, colored after fixation to carnoy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>RNA sequencing analysis of biopsy</measure>
    <time_frame>At the end of study, up to 2 years</time_frame>
    <description>RNA sequencing analysis of rectal biopsy between SPA patients and control subjects.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interaction between bacteria and intestinal epithelial cells</measure>
    <time_frame>At the end of study, up to 2 years</time_frame>
    <description>In order to study the interaction between bacteria and intestinal epithelial cells in culture (organoids).&#xD;
Study the induction of several target genes as peptides anti-microbians, mucin or chemokines by RT-q-PCR.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dysbiosis-induced immune perturbations</measure>
    <time_frame>At the end of study, up to 2 years</time_frame>
    <description>To compare between 2 groups their reactivities of T cells from intestinal biopsy which contact with cells of exposed antigens in vitro, to R. gnavus stains or to other stains biopsied from control subjects.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Spondyloarthritis</condition>
  <condition>Ruminococcus Gnavus</condition>
  <arm_group>
    <arm_group_label>SPA patient</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with SPA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Subject without SPA</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Health subjects without SPA, planned to undergo a digestive endoscopy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Biopsy</intervention_name>
    <description>Biopsy during recto-coloscopy</description>
    <arm_group_label>SPA patient</arm_group_label>
    <arm_group_label>Subject without SPA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients with SPA:&#xD;
&#xD;
          -  Patients ⩾ 18 years;&#xD;
&#xD;
          -  Diagnosed as spondyloarthritis (SpA) according ASAS classification;&#xD;
&#xD;
          -  Affiliated to a social security scheme;&#xD;
&#xD;
          -  Have signed the written informed consent form.&#xD;
&#xD;
        Control subjects:&#xD;
&#xD;
          -  Subjects ⩾ 18 years;&#xD;
&#xD;
          -  Subjects free of SPA and planned for a digestive endoscopy for another indication such&#xD;
             as to explore the risk of colorectal cancer in family member;&#xD;
&#xD;
          -  Affiliated to a social security scheme;&#xD;
&#xD;
          -  Have signed the written informed consent form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects unable to understand the proposed study and/or sign a informed consent form;&#xD;
&#xD;
          -  Pregnant women or breast feeding women;&#xD;
&#xD;
          -  Subjects under guardianship or curatorship;&#xD;
&#xD;
          -  Have taken antibiotic 1 month prior to inclusion;&#xD;
&#xD;
          -  Presenting acute or chronic severe pathology may likely to interfere with the&#xD;
             interpret of outcome;&#xD;
&#xD;
          -  Refusal of subjects to participate to the study;&#xD;
&#xD;
          -  Foreign patients under french AME scheme.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maxime BREBAN, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service de Rhumatologie, Hôpital Ambroise Paré, APHP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maxime BREBAN, MD, PhD</last_name>
    <phone>+33 1 49 09 56 72</phone>
    <email>maxime.breban@aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Service de Rhumatologie, Hôpital Ambroise Paré, APHP</name>
      <address>
        <city>Boulogne-Billancourt</city>
        <zip>92100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Breban M, Tap J, Leboime A, Said-Nahal R, Langella P, Chiocchia G, Furet JP, Sokol H. Faecal microbiota study reveals specific dysbiosis in spondyloarthritis. Ann Rheum Dis. 2017 Sep;76(9):1614-1622. doi: 10.1136/annrheumdis-2016-211064. Epub 2017 Jun 12.</citation>
    <PMID>28606969</PMID>
  </reference>
  <reference>
    <citation>Crost EH, Tailford LE, Monestier M, Swarbreck D, Henrissat B, Crossman LC, Juge N. The mucin-degradation strategy of Ruminococcus gnavus: The importance of intramolecular trans-sialidases. Gut Microbes. 2016 Jul 3;7(4):302-312. Epub 2016 May 25.</citation>
    <PMID>27223845</PMID>
  </reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 16, 2021</study_first_submitted>
  <study_first_submitted_qc>April 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2021</study_first_posted>
  <last_update_submitted>May 14, 2021</last_update_submitted>
  <last_update_submitted_qc>May 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Spondyloarthritis</keyword>
  <keyword>Ruminococcus gnavus</keyword>
  <keyword>Microbiota</keyword>
  <keyword>Dysbiosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spondylarthritis</mesh_term>
    <mesh_term>Dysbiosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

